Invesco Biotechnology & Genome ETF
PBE
PBE
76 hedge funds and large institutions have $46.3M invested in Invesco Biotechnology & Genome ETF in 2020 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 29 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
-2
Holders Change %
-2.56%
% of All Funds
1.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
12
Reduced
29
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.31M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$745K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$611K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$550K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$268K |
